NextFin News - Japan's stock market has spent 2026 near record highs, yet the country's IPO pipeline has dried up to its thinnest level in 14 years. Fundraising from initial public offerings has fallen to the lowest level since 2012, even as the Nikkei 225 climbed roughly 33 percent in the first half of the year. In those six months, only 18 companies listed on the Tokyo Stock Exchange — the fewest since 2011 — raising just $917 million, the smallest haul since 2022. The contrast is the story: Japanese equities are booming, but the primary market that should feed that boom has nearly stopped producing new listings.
The drought runs deeper than a single weak quarter. Through September, 31 companies had gone public on the TSE's three markets, down from 33 a year earlier, with zero listings on the top-tier Prime Market. Small offerings — historically the backbone of Japan's IPO engine — have all but vanished: just 43 deals under $50 million were completed in 2025, the fewest since 2013. Meanwhile, the average time from founding to listing has stretched to a record 15 years, up from 12 to 13, and the average market value at listing hit ¥30.9 billion in the January–August period, the highest since the exchange's 2013 merger. Fewer companies are listing, they are older when they do, and the ones that make it are larger — yet the total capital raised has collapsed.
This is not a cyclical dip that will bounce back when sentiment improves. It is a structural regime shift, engineered in part by the exchange itself. Tokyo Stock Exchange reforms that took effect in late 2025 raised the bar for staying listed, the TOPIX benchmark was remade into a selective index, and private equity sponsors — once the most reliable source of IPO candidates — have rerouted exits into trade sales. The result is a market that is healthier by design but far smaller in volume, and a Japan that is being left behind while the rest of the world's IPO machine roars back to life.
The Paradox: Record Stocks, Empty IPO Pipeline
The numbers frame the contradiction sharply. The Nikkei 225 set a record closing high of 72,366 yen in June 2026, and the broader equity rally has been powered by the same themes — artificial intelligence, semiconductors, data centers — that have fueled IPO booms in the United States and Hong Kong. Yet Japan's listing count tells a different story. In the first nine months of 2026, only 31 companies listed on the TSE: none on Prime, 13 on Standard, and 18 on Growth, down from 33 in the same period a year earlier and the lowest count since comparable data began in 2023.
Proceeds tell an even starker tale. First-half fundraising of $917 million was the lowest since 2022. The one bright spot — taxi-hailing app GO Inc.'s ¥88.6 billion ($553 million) listing in June, which opened at a ¥226 billion market value, with the majority of the offering placed to overseas investors — only underscores how thin the pipeline has become. A single deal accounted for a large share of the year's volume, and market participants noted it demonstrated there had been no notable new listings over the preceding six months.
The drought is also a quality drought in reverse. The average market capitalization at listing for companies on the TSE's emerging markets reached ¥30.9 billion between January and August 2026, about 60 percent higher than a year earlier and the highest since the TSE merged with the Osaka Securities Exchange in 2013. Companies are waiting longer to list: the average age at listing hit 15 years, a record. The small, fast-growing startup IPO that once defined the Japanese market is being replaced by a slower, larger, more selective model — and the aggregate capital raised has fallen to a 14-year low as a result.
Why the Pipeline Broke: Three Structural Shifts
Three forces, each structural rather than cyclical, explain why Japan's IPO market has seized up even as its stock index soars.
First, the Tokyo Stock Exchange deliberately raised the bar. In September 2025, the exchange announced it would tighten listing-maintenance standards on the Growth Market: companies must now sustain a market capitalization of at least ¥10 billion within five years of listing, up from ¥4 billion within ten years. The reform was a direct response to a decade of small listings that raised little capital, reported volatile earnings, and then languished as illiquid, underperforming shells.
It's important for newly listed firms to continue growing after an initial offering and the market is saying 'no' to those companies that can't achieve sustainable growth.
Hiroaki Tomori, an executive fund manager at Mitsubishi UFJ Asset Management, put it that way as the reforms took hold. The exchange's chief executive, Hiromi Yamaji of Japan Exchange Group, framed the goal differently but to the same effect: the reforms are not meant to eliminate smaller IPOs, but to push growth-confident firms to come to market.
Second, the TOPIX benchmark was remade into a selective index. For years, a Prime Market listing carried an automatic reward: inclusion in TOPIX, which forced index-tracking funds to buy the stock. That assumption is gone. A Prime listing no longer guarantees benchmark inclusion, stripping away one of the most reliable sources of post-IPO demand and breaking the "TSE-listed brand" premium that once justified a quick flotation. The reform removes a subsidy to mediocrity — but it also removes a reason to list early.
Third, the private equity exit channel has been diverted. Private equity sponsors, which once fed a steady stream of portfolio companies into the IPO market, have turned to trade sales instead. Valuation gaps between what sellers want and what public-market investors will pay have slowed exit activity, and sponsors cite greater certainty and fewer post-closing risks in selling to strategic buyers. James Beach, a partner at Morrison Foerster, pointed to America's deeper continuation-fund and secondaries markets as the differentiator.
The US has structural exit-pressure valves that Japan largely lacks.
Corporate governance reform has also accelerated industrial carve-outs, which are more likely to end in a sale than a listing. The result is that Japan's IPO pipeline is losing its most reliable supplier at the same time the bar to entry is rising.
The Global Divergence: Everyone Else Is Listing
Japan's drought stands out precisely because the rest of the world is in the middle of an IPO resurgence. Global IPO proceeds reached $93.3 billion in the third quarter of 2026, up 79 percent from a year earlier, according to EY's IPO Barometer. In the first nine months of the year, global issue volume hit a record $287.5 billion, roughly 151 percent higher than the $114.4 billion raised in the same period of 2025. Asia-Pacific ex-Japan raised $29.2 billion in the first half of 2026, up 41.8 percent year over year, per LSEG Data & Analytics. In the United States, IPO proceeds were forecast to quadruple to a record roughly $160 billion for the year.
The starkest contrast is with Hong Kong, which raised $48.4 billion through IPOs in the first nine months of 2026 — the strongest nine-month period since records began in 1980 — led by Chinese AI company listings, according to LSEG data. Japan, by comparison, raised $917 million in the first half alone. The gap is not a matter of investor risk appetite; global capital is clearly willing to fund growth companies. It is a matter of supply. Japan does not have enough listing-ready companies in the sectors that global investors want, and the companies it does have are either waiting longer to mature or exiting through sales.
There is also a competitive dimension. Japanese startups in AI, semiconductors, and data-center infrastructure — the very themes driving the Nikkei's rally — are scarce in the domestic pipeline. Analysts note that Japanese firms with exposure to these themes may find more listing opportunities ahead, but the structural shortage of growth companies means the recovery will be slow. Major investment banks expect market activity to pick up gradually from the end of this year into next year, but participants broadly expect no rapid rebound.
The Counter-Thesis: Reform Is Working as Intended
The strongest argument against the "drought" framing is that the drought is the point. For a decade, Japan's IPO market was large in count but weak in quality. Small deals accounted for about 82 percent of the country's IPOs on average from 2015 to 2024, compared with 76 percent in India and 55 percent in Hong Kong, and many of those listings were prestige plays rather than genuine capital-raising events. Hiroyuki Tada, an executive director in the IPO department at Nomura Securities, sees the shift as a lasting change in issuer behavior.
Appropriate pricing is becoming easier to achieve, especially from the perspective of increased trading after listing. The trend that companies aim for an IPO after getting larger is likely to continue.
Takashi Kaneko, professor emeritus at Keio University, who has collaborated with University of Florida IPO scholar Jay Ritter, argues the decline in smaller listings reduces "distortions in the capital market" and marks Japan's "major turning point in becoming an advanced IPO country." From this view, fewer but larger, better-capitalized listings with deeper liquidity are a sign of market maturation, not dysfunction. The record ¥30.9 billion average market cap at listing and the 15-year average runway to IPO support the case that Japanese companies are building more scale before going public — exactly what policymakers wanted.
This counter-thesis has real force, and it is the view the exchange itself endorses. But it does not fully answer the supply problem. Even if every remaining candidate is higher quality, the pipeline is too thin to serve as an exit channel for Japan's venture and private equity ecosystem, which has been building positions for years and now needs a way to return capital to investors. A market that lists 31 companies in nine months cannot absorb that flow, no matter how high the average quality. The reform may be producing a better market, but it is also producing a smaller one — and a smaller market cannot perform the capital-recycling function that a mature venture ecosystem requires.
The falsifying test is specific: if the annual TSE listing count does not recover toward the historical norm of roughly 35 listings a year and IPO proceeds do not climb back toward pre-reform levels within two years, and if private equity exit volume does not shift back toward IPOs as valuation gaps narrow, then the "maturation" story gives way to a structural supply shortage. Watch the quarterly listing count and the share of PE exits going to IPOs versus trade sales. A sustained recovery toward the historical average with IPOs reclaiming a meaningful share of exits would validate the reform-as-maturation view; continued stagnation well below that pace would confirm the supply-constraint thesis.
What Comes Next: Who Benefits, Who Is Exposed
The implications split by time horizon and by who sits on which side of the transaction.
In the short term, the winners are the companies already large enough to clear the new bar. Firms with ¥10 billion-plus market capitalizations, credible growth narratives in AI or infrastructure, and the scale to attract overseas institutional demand — like GO, which placed the majority of its offering abroad — will find a market that prices them more efficiently precisely because there is less noise from marginal listings. Investment banks with strong institutional distribution and cross-border placement capabilities benefit as the business shifts from volume to value.
The exposed are the small and mid-sized companies that once relied on a quick Growth Market listing as a default exit. For them, the domestic IPO door has narrowed, and the alternatives are limited: sell to a strategic buyer, wait years longer to build scale, or list overseas — where Hong Kong, the US, and other venues are actively courting Asian growth companies. Venture capital funds with portfolios of sub-scale companies face longer hold periods and fewer exit options, which will pressure fund returns and, eventually, fundraising.
Over the medium term, the key variable is whether Japan's shortage of AI and semiconductor growth companies is filled. If the corporate spinouts and governance-driven carve-outs currently in motion reach listing scale, the pipeline could thicken by 2027–2028. If not, Japan's primary market will remain a niche venue while its public equities continue to trade at record levels on the back of existing mega-caps.
Over the long term, the question is whether Japan can rebuild a venture-to-IPO flywheel at all. The pieces exist — record household savings flowing through the new NISA tax-advantaged accounts, deep corporate balance sheets, and a reform-minded exchange. But a flywheel requires exits, and exits require buyers or public markets. If trade sales remain the dominant exit, capital will not recycle back into early-stage companies the way IPO proceeds and founder wealth do, and Japan's startup ecosystem will grow more slowly than its public market.
The base case is a slow, selective recovery: a handful of larger listings per quarter, concentrated in technology and governance-driven carve-outs, with no return to the 2021 peak in the foreseeable future. The upside case requires a surge of listing-ready AI and semiconductor companies emerging over the next 18 to 24 months, combined with a narrowing of the valuation gap that pushes PE sponsors back toward public exits. The downside case is a permanent downsizing: Japan's IPO market settles into a steady state well below its historical average, serving only the largest companies while the rest of the exit market moves to trade sales and offshore venues.
Japan's IPO drought is not a market malfunction. It is the sound of a market being rebuilt — and the bill for that reconstruction is a generation of companies that will never list at all. The Nikkei can hit record highs on the strength of its incumbents; an IPO market cannot.
Explore more exclusive insights at nextfin.ai.
